Concepedia

Publication | Closed Access

Dipeptedyl peptidase-4 (DPP-4) inhibitor downregulates HMGB1/TLR4/NF-κB signaling pathway in a diabetic rat model of non-alcoholic fatty liver disease

11

Citations

28

References

2021

Year

Abstract

Sitagliptin may in fact prove to be a beneficial therapeutic intervention in NAFLD.

References

YearCitations

Page 1